A number of pathologies of pregnancy, including up to 50% of miscarriages, preeclampsia (hypertension and proteinuria in pregnancy), intrauterine growth restriction (IUGR), preterm labour, unexplained stillbirth and placental abruption are characterised by impaired placental differentiation and function. Together these conditions affect more than one quarter of pregnant women in developed societies. Our laboratory takes a "bench to bedside" approach to discovery and solving clinical problems in pregnancy that have their origins in placental development and maternal adaptation to pregnancy. We undertake basic cellular and molecular experiments to elucidate mechanisms that govern normal and abnormal placental development. We also have a strong focus on identifying genetic, nutritional, lifestyle and clinical factors that associate with pregnancy outcome in the SCOPE, PAPO and STOP pregnancy cohorts. Current projects include prediction of pregnancy complications, the role of micronutrients in placental development and pregnancy success, ZIKA virus infection in pregnancy, fetal sex differences in the human placental transcriptome, miRnome and methylome, that is, genome wide control of gene expression, and long term health in women and their children after pregnancy complications.